Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer.
Wang
Jie
J
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Lee
J Jack
JJ
Wang
Luo
L
Liu
Diane D
DD
Lu
Charles
C
Fan
You-Hong
YH
Hong
Waun Ki
WK
Mao
Li
L
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D045744:Cell Line, Tumor; D002764:Cholecystitis / Q000175:diagnosis / Q000235:genetics; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000096:biosynthesis*; D019175:DNA Methylation; D004262:DNA Restriction Enzymes / Q000494:pharmacology; D005260:Female; D005706:Gallbladder Neoplasms / Q000473:pathology; D020868:Gene Silencing; D006801:Humans; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D011401:Promoter Regions, Genetic; D013223:Statistics as Topic; D013447:Sulfites / Q000494:pharmacology; D016896:Treatment Outcome; D025521:Tumor Suppressor Proteins / Q000235:genetics*
D019941:Cyclin-Dependent Kinase Inhibitor p16; C411762:RASSF1 protein, human; D013447:Sulfites; D025521:Tumor Suppressor Proteins; D004262:DNA Restriction Enzymes; C009279:sodium bisulfite